Kinoshita Hidefumi, Kamoto Toshiyuki, Mitsumori Michihide, Kiyokawa Takehiko, Habuchi Tomonori, Kakehi Yoshiyuki, Hiraoka Masahiro, Ogawa Osamu
Department of Urology, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaramachi, Sakyo-ku, Kyoto 606-8507, Japan.
Gan To Kagaku Ryoho. 2003 Jan;30(1):32-7.
Prostate specific antigen (PSA) failure occurs in 20% to 50% of patients who undergo radical prostatectomy. There is no consensus on how PSA failure should be managed. Recently, salvage radiotherapy is reported to be an effective treatment for PSA failure, and 20%-70% of cases are recurrence-free. The aim of salvage radiotherapy is a cure and this is quite different from other options, for example, endocrine therapy. Salvage radiotherapy is likely to become more important as a treatment for PSA failure after radical prostatectomy.
